|
No difference in shivering between
rectally administered misoprostol and oxytocin was observed in our
trial, findings that are consistent with other studies.
In comparing the side effects of rectal to oral msoprostol used for
prevention of postpartum hemorrhage, Khan et al. (14) has shown that
the relative risk of shivering in the rectal group was 73% that of
oral group (95% CL 61%, 86%)
Our study a long with the available literature on rectally administered
misoprostol illustrate that rectal misoprostol seems to be effective
in reducing the likelihood of postpartum haemorrhage after vaginal
delivery at a dose of 400 micrograms.
Conclusion
Rectal misoprostol seems to be safe and effective in preventing postpartum
haemorrhage and is recommended for use in managing the third stage
of labour.
|
|
References
1. O'Brien P, El-Refaey H,
Gordon A, Geary M, Rodeck CH. Rectally administered misoprostol for
treatment of post partum haemorrhage unresponsive to oxytocin and
ergometrin: a descriptive study. Obstet Gynecol 1998 Aug; 92: 212-4.
2. McCormick ML, Sanghvi HC, Kinzie B, McIntosh N. Preventing
postpartum hemorrhage in low -resources. Int J Gynecol obstet.2002
Jun; 77(37): 267-75
3. Rojers J,Wood J Mc Candlish R, Ayers S, Trusdale A,Elbourne
D. Active versus expectant management of third stage of labor : The
Hinchingbrooke randomised controlled trial. Lancet 1998; 39: 693-9.
4. Khan Go, John Wanies, Doberty T, Sibai MB.Controlled cord
traction versus minimal intervention techniques in delivery of placenta:
a randomized controlled trial. Am J Obstet Gynecol 1997; 177: 770-4.
5. El-Refaey H, Noor R, O'Brien P, Abdellah M,Geary M, Walder
J et al. The misoprostol third stage of labor study. Br J Obstet Gynecol
2000; 107:1104-10.
 
|